ACC.26 advanced registration ends Feb. 12 – register now!

Jonathan Salik, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Kiniksa(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Kiniksa(SIGNIFICANT), Cardiol Therapeutics(SIGNIFICANT)

View Full Disclosure